logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
J

Joyce O’Shaughnessy

Baylor University Medical Center

69H指数
666论文数
2.2W被引数
收录论文 183
发表时间
logo
Characterization of ESR1 alterations in patients with breast and gynecologic cancers
errBreast Cancer Research
IF5.6
err2026-01-19
err0
errOAAI
errGargi D. Basu; Paige E. Innis; Angela K. Deem; Arthur Starodynov; Sameer S. Udhane; Szabolcs Szelinger; Min Wang; Janine R. LoBello; Frederick L. Baehner; Jean-Paul De La O; Joyce O’Shaughnessy
err分享
err收藏
Optimizing clinical monitoring and management guidelines for capivasertib in HR-positive/HER2-negative advanced breast cancer: expert opinion优化卡匹瓦塞替在HR阳性/HER2阴性晚期乳腺癌中的临床监测和管理指南：专家意见
errnpj Breast Cancer
IF7.6
err2025-12-04
err0
errOAAI
errNeil M. Iyengar; Joyce A. O’Shaughnessy; Heather B. Moore; Erika Hamilton; Komal L. Jhaveri; Cynthia X. Ma; Karen Tedesco; Monali Vasekar; Sarah Donahue; Hope S. Rugo
err分享
err收藏
Analysis of the Radiosensitivity Index (RSI) in Paired Pre- and Post-Neoadjuvant Therapy Triple-Negative Breast Cancer配对新辅助治疗前后的三阴性乳腺癌中放射敏感性指数(RSI)的分析
errInternational Journal of Radiation Oncology*Biology*Physics
IF0
err2025-09-25
err0
PREAI
errShane R. Stecklein; Roberto Salgado; Julia R. White; Bruce F. Kimler; Rachel Yoder; Joshua M. Staley; Anne P. O’Dea; Lauren E. Nye; Deepti Satelli; Gregory J. Crane; Rashna Madan; Maura F. O’Neil; Andrew K. Godwin; Harsh Pathak; Qamar J. Khan; Joyce O’Shaughnessy; Priyanka Sharma
err分享
err收藏
US expert Delphi consensus on the prevention and management of stomatitis in patients treated with datopotamab deruxtecan美国专家德尔菲共识：datopotamab deruxtecan治疗患者的口腔炎预防与管理
errSupportive Care in Cancer
IF3
err2025-08-05
err0
errOAAI
errHope Rugo; Aditya Bardia; Debora S. Bruno; Vinicius Ernani; Erika Hamilton; Rebecca Heist; Komal Jhaveri; Benjamin Levy; Aaron Lisberg; Joyce O’Shaughnessy; Jacob Sands; Alexander Spira; Sara Tolaney; Nathaniel S. Treister; Cecile Matthews; Melissa Johnson
err分享
err收藏
Limitations in the Application of Clinicopathologic Factors Alone in Predicting Radiation Benefit for Women with Low-Risk Ductal Carcinoma in Situ after Breast Conserving Surgery: The Impact of a 7-gene Biosignature based on 10-Year Ipsilateral Breast Recurrence (IBR) Rates仅依靠临床病理因素预测行保乳术后低风险导管原位癌女性放疗获益的应用局限性：基于10年同侧乳腺复发(IBR)率的7基因生物标志物的影响
errinternational journal of radiation oncology biology physics
IF0
err2025-07-18
err0
PREAI
errFrank Vicini; Chirag Shah; Karuna Mittal; Sheila Weinmann; Michael Leo; G. Bruce Mann; Fredrik Warnberg; Rachel Rabinovitch; Brian Czerniecki; Icro Meattini; Atif Jalees Khan; Sachin Jhawar; Naamit Gerber; Shawna C. Willey; Pat Borgen; Zahraa AlHilli; Megan Kruse; David Dabbs; Steven C. Shivers; Anna Daily; Pat Whitworth; Michael Alvarado; Jason A. Mouabbi; Meena Moran; Hope Rugo; Joyce A. O’Shaughnessy; Troy Bremer
err分享
err收藏
TROPION-Breast05: a randomized phase III study of Dato-DXd with or without durvalumab versus chemotherapy plus pembrolizumab in patients with PD-L1-high locally recurrent inoperable or metastatic triple-negative breast cancerTROPION-Breast05：一项关于Dato-DXd联合或不联合durvalumab与化疗联合pembrolizumab治疗PD-L1高表达局部复发不可手术或转移性三阴性乳腺癌的随机III期研究
errTHERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
IF4.2
err2025-04-17
err0
errOAAI
errPeter Schmid; Mafalda Oliveira; Joyce O’Shaughnessy; Massimo Cristofanilli; Stephanie L. Graff; Seock-Ah Im; Sherene Loi; Shigehira Saji; Shusen Wang; David W. Cescon; Tina Hovey; Agata Nawrot; Karson Tse; Petra Vukovic; Giuseppe Curigliano
err分享
err收藏
Correlation analysis of invasive disease-free survival and overall survival in a real-world population of patients with HR+/HER2-early breast cancerHR+/HER2-早期乳腺癌患者真实世界人群中的侵袭性无病生存期与总生存期相关性分析
errCANCER
IF5.1
err2025-03-30
err0
errOAAI
errGraff, Stephanie L.; Tolaney, Sara M.; Hart, Lowell L.; Razavi, Pedram; Janni, Wolfgang; Schwartzberg, Lee S.; Danyliv, Andriy; Akdere, Murat; Ferrusi, Ilia; Adhikary, Rishi Rajat; O'Shaughnessy, Joyce A.
err分享
err收藏
Neoadjuvant HER2-Targeted Therapy Response by BluePrint Gene Expression-Based Molecular Subtyping in patients with HER2+Early-Stage Breast Cancer from FLEX基于Blueprint基因表达分型的HER2阳性早期乳腺癌患者新辅助HER2靶向治疗反应来自FLEX研究
errBREAST
IF7.9
err2025-02-01
err0
errOAAI
errSamiian, L.; Brufsky, A.; Ugyan, S.; Kapoor, I.; Poillucci, V.; O'Shaughnessy, J.; Audeh, W.
err分享
err收藏
DYNASTY-Breast02: A phase III trial of BNT323/DB-1303 vs investigator's choice chemotherapy in HER2-low, hormone receptor positive, metastatic breast cancerDYNASTY-Breast02：一项比较BNT323/DB-1303与研究者选择化疗方案治疗HER2低表达、激素受体阳性、转移性乳腺癌的III期临床试验
errANNALS OF ONCOLOGY
IF65.4
err2024-09-01
err0
PREAI
errO'Shaughnessy, J.; Cortes, J.; Schmid, P.; Xu, B.; Shao, Z.; Teixeira, L.; Sendur, M. A. N.; Sabanathan, D.; Kim, S-B.; Colleoni, M. A.; Wenger, M.; Lee, J. H.; Gu, V.; Qiu, Y.; Liu, S.; Fang, H.; Shi, R.; Zhu, Z.; Hamilton, E. P.
err分享
err收藏
heredERA Breast Cancer: a phase III, randomized, open-label study evaluating the efficacy and safety of giredestrant plus the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in patients with previously untreated HER2-positive, estrogen receptor-positive locally advanced or metastatic breast cancerheredERA乳腺癌: 一项III期，随机，开放标签研究，评估giredestrant加pertuzumab和曲妥珠单抗的固定剂量组合皮下注射治疗未经治疗的HER2-positive，雌激素受体阳性的局部晚期或转移性乳腺癌患者的疗效和安全性
errBMC CANCER
IF3.4
err2024-05-24
err3
errOAAI
errKuemmel, Sherko; Harper-Wynne, Catherine; Park, Yeon Hee; Franke, Fabio; de Laurentiis, Michelino; Schumacher-Wulf, Eva; Eiger, Daniel; Heeson, Sarah; Cardona, Andres; Ozyilkan, Ozgur; Morales-Vasquez, Flavia; Metcalfe, Ciara; Hafner, Marc; Restuccia, Eleonora; O'Shaughnessy, Joyce
err分享
err收藏
Elacestrant vs standard-of-care in ER+/HER2-advanced or metastatic breast cancer (mBC) with ESR1 mutation: key biomarkers and clinical subgroup analyses from the phase 3 EMERALD trial
errCANCER RESEARCH
IF16.6
err2024-05-02
err5
PREAI
errBardia, Aditya; O'Shaughnessy, Joyce; Bidard, Francois-Clement; Neven, Patrick; Garcia-Saenz, Jose Angel; Aftimos, Philippe; Cortes, Javier; Lu, Janice; Tonini, Giulia; Theall, Kathy Puvana; Paoli, Alessandro; Kaklamani, Virginia
err分享
err收藏
Characterization of MammaPrint UltraLow Risk tumors in more than 1400 patients from the real-world evidence FLEX study
errCANCER RESEARCH
IF16.6
err2024-05-02
err0
PREAI
errGraham, Cathy; Hoskins, Kent; Gadi, Vijayakrishna K.; Hoekstra, Suzanne; Srkalovic, Gordon; Marks, Douglas; Sieling, Beth; Dauer, Patricia; Menicucci, Andrea; Audeh, William; O'Shaughnessy, Joyce
err分享
err收藏
A prospective, international, observational, real world evidence database, and collaborative platform for Investigator-Initiated Studies in Early-Stage Breast Cancer tested with MammaPrint and BluePrint the FLEX Study
errCANCER RESEARCH
IF16.6
err2024-05-02
err0
PREAI
errAlberty-Oller, J. J.; Riley, Lee; Samiian, Laila; Thayer, Sarah; Aseyev, Olexiy; Tedesco, Karen; Poillucci, Victoria; Audeh, William; Jelovac, Danijela; O'Shaughnessy, Joyce
err分享
err收藏
Genomic Landscape of ER positive HER2-low early breast cancers in the FLEX Study: MammaPrint, BluePrint and whole transcriptome analysis
errCANCER RESEARCH
IF16.6
err2024-05-02
err0
PREAI
errSivapiragasam, Abirami; Brufsky, Adam; Linden, Hannah; Hunter, Natasha; Osborne, Cynthia; Diab, Sami; Maganini, Robert; O'Shaughnessy, Joyce; Bupathi, Manojkumar; Lee, Sung Ho; Kim, Theodore Y.; Audeh, William; Haan, Josien; Menicucci, Andrea; Samraj, Lavanya
err分享
err收藏
Clinical Results of Subjects Remaining in the Phase 3 ARTEST Study Enobosarm Therapy in AR+ER+HER2-Metastatic Breast Cancer with 3 or Greater Prior Lines of Therapy
errCANCER RESEARCH
IF16.6
err2024-05-02
err0
PREAI
errRinn, Kristine; Jackson, Elisa Krill; Barnette, Gary; Rodriguez, Domingo; Shalev, Itay; Steiner, Mitchell; O'Shaughnessy, Joyce; Rugo, Hope; Brufsky, Adam
err分享
err收藏
Analysis of the Radiosensitivity Index/Genomic-Adjusted Radiation Dose (RSI-GARD) in Paired Pre- and Post-Treatment TNBC Samples: Implications for Biomarker-Guided Radiotherapy
errCANCER RESEARCH
IF16.6
err2024-05-02
err0
PREAI
errStecklein, Shane; White, Julia; Yoder, Rachel; Staley, Joshua; Schmitt, Zachary; O'Dea, Anne; Nye, Lauren; Satelli, Deepti; Crane, Gregory; Madan, Rashna; O'Neil, Maura; Godwin, Andrew; Pathak, Harsh; Khan, Qamar; O'Shaughnessy, Joyce; Sharma, Priyanka
err分享
err收藏
Design of Active Phase 3 ENABLAR-2 Study Evaluating Enobosarm plus /- Abemaciclib in Patients with AR+ER+HER2-2nd-Line Metastatic Breast Cancer Following Tumor Progression on an Estrogen Blocking Agent Plus Palbociclib or Ribociclib
errCANCER RESEARCH
IF16.6
err2024-05-02
err0
PREAI
errRinn, Kristine; Linden, Hannah; Schwartzberg, Lee; Barnette, Gary; Rodriguez, Domingo; Shalev, Itay; Steiner, Mitchell; Brufsky, Adam; O'Shaughnessy, Joyce
err分享
err收藏
Racial disparities in breast cancer and effect of obesity: MammaPrint, BluePrint and whole transcriptome analyses of tumors in Latin American patients in FLEX trial
errCANCER RESEARCH
IF16.6
err2024-05-02
err0
PREAI
errMazo-Canola, Marcela; Kaklamani, Virginia; Advani, Pooja; Kamaraju, Sailaja; Santillan-Gomez, Alfredo A.; Maganini, Robert; Barone, Julie; Uygun, Sahra; Samraj, Lavanya; Audeh, William; O'Shaughnessy, Joyce
err分享
err收藏
Patients with metastatic triple-negative breast cancer who receive trilaciclib prior to cytotoxic chemotherapy exhibit improved survival after receiving subsequent anticancer therapy
errCANCER RESEARCH
IF16.6
err2024-05-02
err0
PREAI
errGoel, Shom; O'Shaughnessy, Joyce; Lu, Kun-Hui; Beelen, Andrew; Melemed, Symantha; Yi, John; Danso, Michael; Tan, Antoinette
err分享
err收藏
Phase 3 study of neoadjuvant pembrolizumab or placebo plus chemotherapy, followed by adjuvant pembrolizumab or placebo plus endocrine therapy for early-stage high-risk ER+/ HER2-breast cancer: KEYNOTE-756
errCANCER RESEARCH
IF16.6
err2024-05-02
err6
PREAI
errCardoso, Fatima; O'Shaughnessy, Joyce; McArthur, Heather; Schmid, Peter; Cortes, Javier; Harbeck, Nadia; Telli, Melinda; Cescon, David; Fasching, Peter A.; Shao, Zhimin; Loirat, Delphine; Park, Yeon Hee; Fernandez, Manuel Gonzalez; Rubovszky, Gabor; Im, Seock-Ah; Hui, Rina; Takano, Toshimi; Andre, Fabrice; Yasojima, Hiroyuki; Liu, Zhenzhen; Ding, Yu; Jia, Liyi; Karantza, Vassiliki; Tryfonidis, Konstantinos; Bardia, Aditya
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
B
Bert Vogelstein
H 指数: 255 · 论文数: 1.0K
K
Kenneth W. Kinzler
H 指数: 213 · 论文数: 785
C
Charles M. Perou
H 指数: 193 · 论文数: 2.0K
G
Gabriel N. Hortobágyi
H 指数: 187 · 论文数: 1.9K
E
Eric P. Winer
H 指数: 170 · 论文数: 1.6K
查看更多